Venture Capital/Emerging Company
With a long history of success, our attorneys have extensive experience advising new and emerging companies with all aspects of their formation, growth, financing and development. We represent young and long-standing companies as well as investors in corporate transactions and securities compliance. Our corporate team negotiates and structures venture capital, angel and other institutional investments, establishes equity compensation programs and provides other services related to the growth of enterprises. Additionally, we leverage our relationships with venture capital firms and other individual and institutional investors to help entrepreneurial clients seek funding.
Carr & Ferrell's services span the entire growth cycle of a company, from organization and incorporation, through venture, mezzanine and late-stage funding, to sophisticated financing and acquisition transactions for large, multinational companies. Our lawyers have extensive experience working with a wide range of traditional and non-traditional financing structures.
Whether a venture firm is looking to make an investment or a young company is seeking funding, clients benefit from our substantial experience in the venture capital marketplace. Since Carr & Ferrell’s inception, we have handled venture financings ranging from several hundred thousand dollars to over ninety million dollars. We have relationships with leading venture capital firms and provide clients with valuable access to a variety of financing resources.
At Carr & Ferrell, we take the time to develop a deep understanding of our clients’ industries, and focus senior-level attention on the issues our clients face. The firm’s experience counseling growing companies spans many industries, including information technology, consumer products and entertainment. Our technology experience includes mobile software and apps, embedded software, wireless communication, assorted forms of e-commerce and marketing, multi-media, content providers, wireless, broadband communications, infrastructure technology, and computer hardware. Within the life sciences industry, we represent biotechnology, medical device and pharmaceutical companies.